Skip Nav Destination
1-1 of 1
Journal: Clinical Science
Clin Sci (Lond) (2014) 127 (7): 423–433.
Published: 17 June 2014
.... Recently, the Ca 2+ -activated K + channel K Ca 3.1 (KCa3.1) has been suggested as a potential therapeutic target for nephropathy, based on its ability to regulate Ca 2+ entry into cells and modulate Ca 2+ -signalling processes. In the present review, we focus on the physiological role of K Ca 3.1 in those...